Why MEMS®
35 Years
Our company was founded 35 years ago in California, USA. Since then, we have steadily innovated to bring the most effective adherence-enhancing solutions to the market. The scientific contribution of our company in medication adherence is recognized worldwide.
Audited by the 10 largest pharma companies
Our company, products and services have been audited by the 10 largest pharma companies. All MEMS® products are tested individually several times throughout production and shipment to meet the highest quality of requirement standards.
Precision Made in Switzerland
Our MEMS® is developed and manufactured in Switzerland -- The 8th generation of MEMS® has a resolution of 1 sec and precision comparable to the most famous swiss quartz watches (almost perfect precision with a variation of only a few seconds per month).
Cloud-based solution
All data is stored and usable on our cloud platform.
36 month battery life
Our MEMS® adherence hardware are the only professional solutions that are self-sufficient for at least 36 months without any charging.
Patent protected
We have several patents covering our hardware, software, and algorithmic solutions.
Collecting sound and reliable data is mission critical for us
Our solution is not built as a “best we can” approach but as a “mission critical” to collect, store and transmit sound and secure data.
Designed to function worldwide
Our solutions are designed to function globally without the need for a communication network or power source. They were tested all around the world under all types of climate and in diverse conditions.
8th generation of product refinement
AARDEX is currently on the 8th generation of MEMS® technology after 35 years of evolution and refinements.
NFC Compliant
All MEMS® adherence hardware solutions are NFC compliant and can be read with a NFC reader. The NFC technology is based on radio close contact communication following the same principle of security as the most recent generation of passports.
Using this technology, the patient is always empowered as the actor of his dosing history data transmission.
814 peer-reviewed papers
MEMS® solutions have been used in a multitude of indications and settings and have resulted in over 800 peer-reviewed published papers reporting studies.
These papers have jointly been cited over 65,000 times and the most-cited MEMS® paper has > 4000 journal citations resulted in a H-index of 144.
Usable without any necessary configuration by patients
Patients are empowered. MEMS® is non-intrusive and completely friction free for patients. We eliminate the need to combine an app, a phone, nor to recharge/change the battery. MEMS® is globally recognized as the easiest to use, install and maintainable solution.